Interlakes Foundation, Incorporated

Rochester, New York 14623

0 studies enrolling now · 1 studies all time

What they study most

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung

Studies at this site

• BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation — Completed